NEOG INVESTORS: Kirby McInerney LLP Notifies Neogen Corporation Investors of Class Action Lawsuit and Encourages Investors to Contact the Firm

New York, New York--(Newsfile Corp. - July 21, 2025) - The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Western District of Michigan on behalf of those who acquired Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG) securities during the period of January 25, 2023 to June 3, 2025, inclusive ("the Class Period"). Investors have until September 16, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

[LEARN MORE ABOUT THE CLASS ACTION]

On January 10, 2025, Neogen revealed that GAAP net income in the second quarter was significantly negative due to a $461 million non-cash goodwill impairment charge related to the acquisition of food safety business of 3M and cut its FY25 revenue and EBITDA guidance. Neogen also revealed that, as of November 30, 2024, the Company had material weaknesses in its internal control over financial reporting. On this news, the price of Neogen shares declined by approximately 5%, from $13.07 on January 8, 2025 to close at $12.36 per share on January 10, 2025.

On April 9, 2025, Neogen announced that quarterly revenue fell 3.4% to $221 million due to integration issues and again cut its FY25 guidance and noted that capital expenditures were expected to be $100 million as a result of lowered adjusted EBITDA and a pull-forward of integration-related capital expenditures into FY25. Neogen also announced that CEO John Adent would be stepping down. On this news, the price of Neogen shares declined by approximately 28%, from $7.04 on April 8, 2025 to close at $5.02 per share on April 9, 2025.

On June 4, 2025, Neogen disclosed a material decline in EBITDA margin, which the Company blamed "elevated inventory writeoffs." On this news, the price of Neogen shares declined by approximately 17%, from $6.00 on June 3, 2025 to close at $4.96 per share on June 4, 2025.

The lawsuit alleges that throughout the Class Period, Neogen misrepresented the status of the 3M integration and failed to disclose the negative impact of integration issues on the financial health of the Company, which led investors to believe that the integration was progressing smoothly. Neogen downplayed integration "inefficiencies" and assured investors that they were fully aware and committed to resolving the issues quickly.

If you purchased or otherwise acquired Neogen securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com or fill out the form below, to discuss your rights or interests with respect to these matters without any cost to you.

CONTACT FORM

Kirby McInerney LLP is a New York-based plaintiffs' law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm's efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP's website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/259551